Clearance Summary
FIBERGRAFT Aeridyan Matrix Bone Graft Substitute received FDA 510(k) clearance under submission number K213803, sponsored by Prosidyan, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2022-08-23.
- Submission: K213803
- Applicant / Sponsor: Prosidyan, Inc.
- Clearance pathway: Traditional
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3045
- Decision date: 2022-08-23
Classification & Regulation
This clearance is catalogued under FDA product code MQV and 21 CFR 888.3045, within the Orthopedic review panel as a Class II device.